Clinical Trial Update: A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports the completion of a study evaluating whether elinzanetant affects driving ability and brain function in healthy women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hot Flashes
• Vasomotor Symptoms

Drugs mentioned

• Elinzanetant (elinzanetant)

Snippet

Sponsor: Bayer | Conditions: Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes | Phase 1 | Status: COMPLETED